BIG
PHAT icon

Brooklyn Investment Group’s Phathom Pharmaceuticals PHAT Stock Holding History

Brooklyn Investment Group’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,718
Closed -$26.1K – 2116
2025
Q2 		$26.1K Sell
2,718
-738
-21% -$4.08K ﹤0.01% 1706
2025
Q1 		$21.7K Buy
+3,456
New +$21K ﹤0.01% 1129

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Brooklyn Investment Group's PHAT Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Phathom Pharmaceuticals (PHAT) in Q3 2025, closing a stake of 2,718 shares — an estimated $26.1K sold.

Brooklyn Investment Group first reported a position in PHAT in Q1 2025 and held it in 2 quarters. The position peaked at $26.1K in Q2 2025. 133 funds tracked by Wall St. Rank hold PHAT as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Phathom Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 2,718 Phathom Pharmaceuticals shares in Q3 2025, an estimated $26.1K.
  • Brooklyn Investment Group first reported a position in Phathom Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • Brooklyn Investment Group's Phathom Pharmaceuticals position peaked at $26.1K in Q2 2025.
  • 133 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.